However, that our hypothesis and the current model have validity in human neurodegenerative disease has been demonstrated in recent and ongoing clinical studies: carer-reported systemic infection and elevated concentrations of IL-1β in sera were independently associated with accelerated cognitive decline in Alzheimer's disease patients (48). Here, IL1B is linked to early-onset autosomal dominant Alzheimer disease.